Investing in tomorrow’s biotech success
Novo Ventures is one of the most active life science venture capital investors in the world. So far, we have invested DKK 8 billion in more than 120 companies and successfully exited over 30 companies through trade sales and IPOs.
We proudly share our positive track record with the talented scientists and inspired entrepreneurs who convert our capital and commercial support into revolutionising products and technologies. Together, we’re improving the lives of thousands of people around the world.
”Significant value can be created through close collaboration between skilled life science investors and dedicated entrepreneurs”
Thomas Dyrberg, Managing Partner, Novo Ventures.
An active partner…
We achieve results through long-term commitment and active collaboration. By working closely with our portfolio companies, we provide the commercial and scientific expertise to help them grow.
…with an international platform ...
With activities in Copenhagen, San Francisco, Boston and London – and an international network of commercial and scientific specialists – we’re geared to reach the major hubs of life science. As a small team with short decision lines, we’re quick to respond to investment opportunities when they arise.
…and long-term commitment
Our venture investment activities are structured as an open evergreen fund with Novo A/S as the sole investor. This allows us to take a long-term perspective when we make our investments. It also frees us from the frameworks that many traditional venture capital funds are bound by.